Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    16810012 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Condition: Significant Bleeding Risk
Interventions: Drug: Octaplex;   Drug: Beriplex P/N (Kcentra)
2 Unknown  Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery
Conditions: Gastric Cancer;   Pancreatic Cancer;   Hepatocellular Cancer;   Colon Cancer
Interventions: Drug: Tranexamic acid;   Other: Standard of care
3 Completed Use of ROTEM for Multi-level Spine Surgery
Condition: Coagulation
Intervention:

Indicates status has not been verified in more than two years